1988
DOI: 10.1111/j.1440-1754.1988.tb01387.x
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal diagnosis and carrier detection by DNA studies in a Duchenne muscular dystrophy family with no living affected male

Abstract: Restriction fragment length polymorphism studies and gene dosage analysis using the intragenic probes pERT87 were used to detect deletions in potential carriers in a family with Duchenne muscular dystrophy in which the only affected male was deceased. Two females were found to have inherited the paternal pERT87 alleles but not the maternal alleles, suggesting that they have inherited the pERT87 deletion from their mothers. The hybridization signals of pERT87 from these two females upon gene dosage analysis als… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1991
1991
1991
1991

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Most cases of D M D and BMD are caused by deletions of the dystrophin gene observable with either cDNA probes or genomic probes within the D M D gene (Koenig et al, 1987(Koenig et al, , 1989Bartlett et al, 1988a,b;Baumbach et al, 1989). When a deletion is found in a patient, it is possible to offer simple prenatal diagnosis to family members and accurate carrier detection for female family members by dosimetry (Hejtmancik et al, 1986;Laing et al, 1989), pulsed-field gel electrophoresis (den Dunnen et al, 1987;Chen et al, 1988b), or, elegantly and almost irrefutably, when the deletion involves a polymorphic probe, through noninheritance of parental alleles or heterozygosity: deletion segregation (Bartlett et al, 1987;Bmresen et al, 1988;Chen et al, 1988a;Speer et al, 1988;Wapenaar et al, 1988;Francke et al, 1989). One restriction enzyme of choice for screening patients 0 197-385 1 /9 1/0 10063-O5$05.…”
Section: Introductionmentioning
confidence: 99%
“…Most cases of D M D and BMD are caused by deletions of the dystrophin gene observable with either cDNA probes or genomic probes within the D M D gene (Koenig et al, 1987(Koenig et al, , 1989Bartlett et al, 1988a,b;Baumbach et al, 1989). When a deletion is found in a patient, it is possible to offer simple prenatal diagnosis to family members and accurate carrier detection for female family members by dosimetry (Hejtmancik et al, 1986;Laing et al, 1989), pulsed-field gel electrophoresis (den Dunnen et al, 1987;Chen et al, 1988b), or, elegantly and almost irrefutably, when the deletion involves a polymorphic probe, through noninheritance of parental alleles or heterozygosity: deletion segregation (Bartlett et al, 1987;Bmresen et al, 1988;Chen et al, 1988a;Speer et al, 1988;Wapenaar et al, 1988;Francke et al, 1989). One restriction enzyme of choice for screening patients 0 197-385 1 /9 1/0 10063-O5$05.…”
Section: Introductionmentioning
confidence: 99%